Search Results - "Gottschalk, R"

Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer by Hsu, Charles C., MD, PhD, Hsu, Howard, MD, Pickett, Barby, MS, Crehange, Gilles, MD, PhD, Hsu, I-Chow Joe, MD, Dea, Ryan, BS, Weinberg, Vivian, PhD, Gottschalk, Alexander R., MD, PhD, Kurhanewicz, John, PhD, Shinohara, Katsuto, MD, Roach, Mack, MD

“…Purpose To assess the feasibility of magnetic resonance imaging (MRI)-planned partial salvage permanent prostate implant (psPPI) among patients with…”
Get full text

Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California–San Francisco experience by Lee, Brian, M.D., Ph.D, Shinohara, Katsuto, M.D, Weinberg, Vivian, Ph.D, Gottschalk, Alexander R., M.D., Ph.D, Pouliot, Jean, Ph.D, Roach, Mack, M.D, Hsu, I.-Chow, M.D

“…Purpose: The aim of this study was to evaluate the feasibility and safety of salvage high-dose-rate (HDR) brachytherapy for locally recurrent prostate cancer…”
Get full text

Stereotactic Body Radiotherapy as Monotherapy or Post–External Beam Radiotherapy Boost for Prostate Cancer: Technique, Early Toxicity, and PSA Response by Jabbari, Siavash, M.D, Weinberg, Vivian K., Ph.D, Kaprealian, Tania, M.D, Hsu, I-Chow, M.D, Ma, Lijun, Ph.D, Chuang, Cynthia, Ph.D, Descovich, Martina, Ph.D, Shiao, Stephen, M.D., Ph.D, Shinohara, Katsuto, M.D, Roach, Mack, M.D, Gottschalk, Alexander R., M.D.,Ph.D

“…Purpose High dose rate (HDR) brachytherapy has been established as an excellent monotherapy or after external-beam radiotherapy (EBRT) boost treatment for…”
Get full text

Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns by Hochstenbach, Kevin, van Leeuwen, D M, Gmuender, H, Gottschalk, R W, Stølevik, S B, Nygaard, U C, Løvik, M, Granum, B, Namork, E, Meltzer, H M, Kleinjans, J C, van Delft, J H M, van Loveren, Henk

“…A crucial period for the development of the immune system occurs in utero. This results in a high fetal vulnerability to immunotoxic exposure, and indeed,…”
Get full text

Loss of PTEN facilitates HIF-1-mediated gene expression by Zundel, W, Schindler, C, Haas-Kogan, D, Koong, A, Kaper, F, Chen, E, Gottschalk, A R, Ryan, H E, Johnson, R S, Jefferson, A B, Stokoe, D, Giaccia, A J

“…In glioblastoma-derived cell lines, PTEN does not significantly alter apoptotic sensitivity or cause complete inhibition of DNA synthesis. However, in these…”
Get full text

Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy by Schiffner, Daniel C., M.D, Gottschalk, Alexander R., M.D., Ph.D, Lometti, Michael, M.S, Aubin, Michele, M.Sc.E.E, Pouliot, Jean, Ph.D, Speight, Joycelyn, M.D., Ph.D, Hsu, I.-Chow, M.D, Shinohara, Katsuto, M.D, Roach, Mack, M.D

“…Purpose: The aim of this study was to measure interfraction prostate bed motion, setup error, and total positioning error in 10 consecutive patients undergoing…”
Get full text

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes by Kaprealian, Tania, M.D, Weinberg, Vivian, Ph.D, Speight, Joycelyn L., M.D., Ph.D, Gottschalk, Alexander R., M.D., Ph.D, Roach, Mack, M.D, Shinohara, Katsuto, M.D, Hsu, I.-Chow, M.D

“…Purpose This is a retrospective study comparing our experience with high-dose-rate (HDR) brachytherapy boost for prostate cancer, using two different…”
Get full text

Mandatory reporting of antimicrobial-resistant pathogens. What should, what can be achieved? : assessment related to the particular facility seems crucial by Heudorf, Ursel, Gottschalk, R, Exner, M

“…Antimicrobial-resistant organisms are regarded as a particular threat to the public health of the European population. In Germany the requirement for a…”
Get full text

Dose Gradient Near Target–Normal Structure Interface for Nonisocentric CyberKnife and Isocentric Intensity-Modulated Body Radiotherapy for Prostate Cancer by Hossain, Sabbir, Ph.D, Xia, Ping, Ph.D, Huang, Kim, M.D, Descovich, Martina, Ph.D, Chuang, Cynthia, Ph.D, Gottschalk, Alexander R., M.D., Ph.D, Roach, Mack, M.D, Ma, Lijun, Ph.D

“…Purpose The treatment planning quality between nonisocentric CyberKnife (CK) and isocentric intensity modulation treatment was studied for hypofractionated…”
Get full text

Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes by Garcia, Maurice M, Gottschalk, Alexander R, Brajtbord, Jonathan, Konety, Badrinath R, Meng, Maxwell V, Roach, 3rd, Mack, Carroll, Peter R

“…Bladder radiotherapy is a management option for carefully selected patients with muscle-invasive bladder cancer. However, the inability to visualize the tumor…”
Get full text

ACR Appropriateness Criteria Prostate Cancer—Pretreatment Detection, Staging, and Surveillance by Eberhardt, Steven C., MD, Carter, Scott, MD, Casalino, David D., MD, Merrick, Gregory, MD, Frank, Steven J., MD, Gottschalk, Alexander R., MD, PhD, Leyendecker, John R., MD, Nguyen, Paul L., MD, Oto, Aytekin, MD, Porter, Christopher, MD, Remer, Erick M., MD, Rosenthal, Seth A., MD

“…Prostate cancer is the most common noncutaneous male malignancy in the United States. The use of serum prostate-specific antigen as a screening tool is…”
Get full text

Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations by Schilling, S., Maltezou, H.C., Fusco, F.M., De Iaco, G., Brodt, H.-R., Bannister, B., Brouqui, P., Carson, G., Puro, V., Gottschalk, R., Ippolito, G., Vetter, Norbert, Kojouharova, Mira, Parmakova, Kremena, Skinhoej, Peter, Siikamaki, Heli, Perronne, Christian, Adrami, Olga, Lambert, John, Lanini, Simone, Hemmer, Robert, Borg, Michael, Fjellet, Anne Lise, Brantsæter, Arne Broch, Horban, Andrzej, Strle, Franc, Trilla, Antoni

“…Highly infectious diseases (HIDs) are defined as being transmissible from person to person, causing life-threatening illnesses and presenting a serious public…”
Get full text

Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes by Garcia, Maurice M, Gottschalk, Alexander R, Brajtbord, Jonathan, Konety, Badrinath R, Meng, Maxwell V, Roach, 3rd, Mack, Carroll, Peter R

“…[This corrects the article DOI: 10.1371/journal.pone.0089754.]…”
Get full text

Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial by Shee, Kevin, de la Calle, Claire M., Chang, Albert J., Wong, Anthony C., Feng, Felix Y., Gottschalk, Alexander R., Carroll, Peter R., Nguyen, Hao G.

“…Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer. Here we present results from a phase 2 trial designed to…”
Get full text

Evaluation of ultrasound-based prostate localization for image-guided radiotherapy by Langen, K M, Pouliot, J, Anezinos, C, Aubin, M, Gottschalk, A R, Hsu, I-C, Lowther, D, Liu, Y-M, Shinohara, K, Verhey, L J, Weinberg, V, Roach, 3rd, M

“…To evaluate the use of the ultrasound-based BAT system for daily prostate alignment. Prostate alignments using the BAT system were compared with alignments…”
Get more information

Letter to the Editor: A response to ‘What is lameness and what (or who) is the gold standard to detect it?’ by Adair, S., Baus, M., Bell, R., Boero, M., Bussy, C., Cardenas, F., Casey, T., Castro, J., Davis, W., Erskine, M., Farr, R., Fischer, A., Forbes, B., Ford, T., Genovese, R., Gottschalk, R., Hoge, M., Honnas, C., Hunter, G., Joyce, J., Kaneps, A., Keegan, K., Kramer, J., Labens, R., Lischer, C., Marshall, J., Oosterlinck, M., Radue, P., Redding, R., Reed, S., Rick, M., Santschi, E., Schoonover, M., Schramme, M., Schumacher, J., Stephenson, R., Thaler, R., Nielsen, J. V., Wilson, D.

Get full text

Patient dose considerations for routine megavoltage cone-beam CT imaging by Morin, Olivier, Gillis, Amy, Descovich, Martina, Chen, Josephine, Aubin, Michèle, Aubry, Jean-François, Chen, Hong, Gottschalk, Alexander R., Xia, Ping, Pouliot, Jean

“…Megavoltage cone-beam CT (MVCBCT), the recent addition to the family of in-room CT imaging systems for image-guided radiation therapy (IGRT), uses a…”
Get full text

Response to Letter to the Editor: Do we have to redefine lameness in the era of quantitative gait analysis by Adair, S., Baus, M., Belknap, J., Bell, R., Boero, M., Bussy, C., Cardenas, F., Casey, T., Castro, J., Davis, W., Erskine, M., Farr, R., Fischer, T., Forbes, B., Ford, T., Genovese, R., Gottschalk, R., Hoge, M., Honnas, C., Hunter, G., Joyce, J., Kaneps, A., Keegan, K., Kramer, J., Lischer, C., Marshall, J., Oosterlinck, M., Radue, P., Redding, R., Reed, S. K., Rick, M., Santschi, E., Schoonover, M., Schramme, M., Schumacher, John, Stephenson, R., Thaler, R., Vedding Neilsen, J., Wilson, D. A.

Get full text

Dysregulation of PTEN and Protein Kinase B Is Associated with Glioma Histology and Patient Survival by ERMOIAN, Ralph P, FURNISS, Constance S, LAMBORN, Kathleen R, BASILA, Daniel, BERGER, Mitchel S, GOTTSCHALK, Alexander R, NICHOLAS, M. Kelly, STOKOE, David, HAAS-KOGAN, Daphne A

“…Purpose: This study assessed whether putative effectors of phosphatidylinositol3-kinase, including PTEN, protein kinase B (PKB), and p27 kip1 , correlate with…”
Get full text

Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT by Hossain, Sabbir, Xia, Ping, Chuang, Cynthia, Verhey, Lynn, Gottschalk, Alexander R., Mu, Guanwei, Ma, Lijun

“…Hypofractionated stereotactic body radiotherapy (SBRT) has been tested for prostate cancer radiotherapy. This study aims to investigate the dosimetric effects…”
Get full text